相關搜尋:
COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1 variant that was dominant earlier this year could neutralize ...
Reuters
6 小時前
Forbes
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
2 日前
South China Morning Post
Singapore slams opposition claims linking Covid vaccines to excess deaths
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
5 日前
CNBC
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
The Wall Street Journal
Moderna Looks for Boost From Newly Approved RSV Shot
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
7 日前
After A 40% Fall Is Walgreens Stock A Better Pick Over CVS Health?
14 小時前
查看全部
Hong Kong COVID-19 vaccination programme
接種計劃分別採用由BioNTech開發的復必泰以及由科興生物開發的克爾來福兩款疫苗。計劃於2021年2月26日展開。 維基百科
新冠疫苗異常事件
疫苗通行證
第三針
強制檢測名單
港康碼